[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100575626":3},{"organization":4,"armGroups":7,"interventions":7,"overallOfficials":7,"centralContacts":8,"locations":14,"responsibleParty":28,"collaborators":7,"id":30,"slug":7,"hasResults":31,"nctId":32,"briefTitle":33,"officialTitle":34,"acronym":7,"eligibilityCriteria":35,"healthyVolunteers":31,"sex":36,"minAge":37,"maxAge":7,"enrollmentInfo":38,"targetDuration":41,"studyType":42,"phases":7,"briefSummary":43,"conditions":44,"keywords":7,"overallStatus":16,"whyStopped":7,"lastUpdateSubmitDate":47,"lastUpdatePostDateStruct":48,"startDateStruct":51,"completionDateStruct":53,"leadSponsor":55,"locationsCount":56},{"fullName":5,"class":6},"IRCCS Azienda Ospedaliero-Universitaria di Bologna","OTHER",null,[9],{"name":10,"role":11,"phone":12,"phoneExt":7,"email":13},"Vincenzo Lucidi, MD","CONTACT","+39 3385246923","vincenzo.lucidi@aosp.bo.it",[15],{"facility":5,"status":16,"city":17,"state":7,"zip":18,"country":19,"cosmosGeoPoint":20,"geoPoint":25,"contacts":26},"RECRUITING","Bologna","40138","Italy",{"type":21,"coordinates":22},"Point",[23,24],11.33875,44.49381,{"lat":24,"lon":23},[27],{"name":10,"role":11,"phone":12,"phoneExt":7,"email":13},{"type":29,"investigatorFullName":7,"investigatorTitle":7,"investigatorAffiliation":7,"oldNameTitle":7,"oldOrganization":7},"SPONSOR","100575626",false,"NCT06774729","Development of a Radiomics Model With MR to Predict the Occurence of a Infiltration of Muscoskeletal Tumor","Development of a Radiomics Model With 3T Multiparametric MR to Predict the Occurence of a Perilesional Infiltration of Muscoskeletal Tumor During the Pre- Surgery Planning","Inclusion Criteria:\n\n* Age over 18\n* suspect of soft tissue sarcoma with a indication for surgical treatment\n* suspect of bone cancer tumor with a indication for surgical treatment\n* To give informed consent\n\nExclusion Criteria:\n\n* simultaneous cancer or history of cancer in the last 5 years\n* acute or chronic serious conditions that could\n* contraindication to conduct a Contrast-enhanced magnetic resonance imaging (MRI) such as:\n\n  * renal failure without dialysis\n  * history of allergy to a paramagnetic contrast agent\n  * claustrophobia\n  * symptomatic epilepsy or history of epilepsy\n  * cardiac pacemaker\n  * infusion pump, prosthesis or any implant not compatible with MRI\n  * pregnancy","ALL","18 Years",{"count":39,"type":40},122,"ESTIMATED","2 Years","OBSERVATIONAL","The goal of this observational study is to evaluate the feasibility and clinical utility of radiomics to diagnose peri-lesion tumour infiltration of tumours in participants with a suspect of Bone Cancer Tumor or Soft Tissue Sarcoma (STS).\n\nThe main questions it aims to answer are:\n\n* is radiomics able to identify the ratio of participants truly diagnosed as positive to all those who had positive test results?\n* is radiomics able to identify the likelihood that a participant who has a negative test result indeed does not have the disease?\n\nParticipants eligible for this study will get a MRI as part of their regular medical care. The only difference is that their data will be recorded and anonymously analyzed.",[45,46],"Soft Tissue Sarcoma (STS)","Bone Cancer Tumor","2025-01-09",{"date":49,"type":50},"2025-01-14","ACTUAL",{"date":52,"type":40},"2025-03",{"date":54,"type":40},"2028-10",{"name":5,"class":6},1]